JPRN-UMIN000000544已完成未知
Impact of Acarbose Therapy in Abnormal Glucose Tolerance Patients with Coronary Artery Disease - ATAC Study
Cardiovascular Center,Anjo Kosei Hospital0 个研究点目标入组 100 人开始时间: 2007年7月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Any subject who applies to the article below shall be excluded. 1) Patients on oral antidiabetic or insulin preparation 2) Patients with a history of ileus or undergone laparotomy 3) Patients with severe liver dysfunction or renal dysfunction 4) Patients with serious case of ketosis or diabetical coma, or precoma 5) Patients with severe infection disease, or in the perioperative period, or with extreme trauma 6) Patients with gastrointestinal problems such as diarrhea, vomiting 7) Patients with a history of sensitivity to Acarbose 8) Pregnant or possibly pregnant women 9) Patients judged by the investigator/subinvestigator to be ineligible for some other reason
研究者
相似试验
已完成
3 期
Acarbose and Secondary Prevention After Coronary StentingGlucose Metabolism DisordersCoronary Artery DiseaseNCT00221156Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan300
已完成
不适用
A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)Impaired glucose tolerance (IGT)JPRN-UMIN000001109Takeda Pharmaceutical Company Limited1,782
Unknown
不适用
Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 DiabetesImpaired Glucose ToleranceDiabetes MellitusNCT00417950Taichung Veterans General Hospital30
招募中
不适用
The effect of Metformin on acute inflammation of the body during Periodontal Treatment in non-Diabetic patientsPeriodontitisRBR-48rdt69uciana Satie Okajima
已完成
4 期
The Efficacy and Tolerability of Acarbose in Healthy IndividualsToleranceSide EffectGlucose ResponseNCT05542849AgelessRx15